Why Is Omniab Stock Rallying After Eli Lilly Deal?
The OmniAb Lilly Deal offers up to $370 million in milestones as OABI raises its 2026 cash outlook and shares jump premarket
OmniAb made a deal with a big drug company (Eli Lilly) that could earn them up to $370 million if things go well, so they're feeling more confident about their money situation and people want to buy their stock.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.